Adicet Bio Inc
Statements
Cash Flow
Adicet Bio Inc (ACET) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -20 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 11 | 9.6 | 11 | 0.3 | 44 | -32 | -7.3 | 0.4 | 0.6 | -57 | -7.6 | -5.7 | -7.2 | -7.3 | -8.4 | -12 | -7.8 | -13 | -15 | -13 | -9.7 | -13 | 4.1 | -15 | -15 | -19 | -24 | -25 | -21 | -23 | -23 | -23 | -22 | -24 | -25 | -27 | -22 | -21 | -21 | -20 | -85 | |
| 4.6 | 5.2 | 10 | -3.8 | 10 | -12 | 0.0 | 4.6 | 9.9 | -12 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.5 | 0.4 | 0.4 | 0.4 | 0.4 | 0.8 | 1.1 | 1.3 | 1.5 | 1.6 | 1.7 | 1.7 | 1.6 | 1.3 | 1.6 | 1.7 | 1.7 | 1.6 | 1.5 | 1.3 | 1.2 | 5.6 | |
| 1.7 | 2.1 | 1.5 | 1.5 | – | -4.6 | 1.2 | 0.4 | 0.6 | -2.3 | 0.3 | 0.2 | 0.4 | 0.3 | 0.3 | 0.4 | 3.0 | 1.6 | 3.0 | 2.7 | 2.5 | 4.3 | 4.4 | 4.3 | 4.2 | 4.3 | 4.8 | 5.0 | 5.6 | 4.9 | 5.7 | 6.0 | 6.8 | 3.8 | 3.2 | 2.9 | 2.5 | 5.7 | 1.3 | 1.4 | 11 | |
| 2.9 | 0.5 | 1.8 | 9.5 | 2.7 | 6.6 | 170 | 96 | -0.6 | – | 0.1 | -1.7 | 0.2 | – | 0.2 | 0.4 | 3.9 | 2.8 | 7.8 | -0.5 | 3.5 | 4.4 | 5.0 | 5.0 | 4.6 | 5.0 | 5.8 | 5.8 | 26 | – | – | – | – | – | – | – | – | – | – | – | – | |
| 14 | 13 | 9.1 | -11 | -0.1 | -11 | 0.1 | -186 | 148 | -11 | -1.2 | 1.0 | 0.3 | -1.0 | -4.4 | -4.2 | 2.6 | -7.5 | -2.1 | -1.8 | 0.3 | -2.5 | -5.9 | 2.4 | 1.3 | 4.9 | 0.2 | 0.2 | 1.2 | -1.4 | -3.0 | -1.9 | 4.9 | -0.2 | -1.7 | 0.1 | 0.5 | 2.6 | -3.8 | -3.1 | -3.8 | |
| 0.5 | 0.1 | 0.7 | 0.3 | 1.5 | 0.5 | 0.3 | 2.8 | 0.2 | 0.2 | 0.2 | 0.3 | 0.1 | 0.5 | 0.3 | 0.1 | 0.2 | 0.4 | 0.7 | 2.1 | 7.2 | 3.1 | 2.6 | 2.8 | 4.8 | 6.5 | 1.9 | 1.5 | 0.9 | 0.1 | 0.2 | 0.3 | 0.4 | 0.2 | 1.5 | 0.0 | 0.2 | 0.0 | 0.0 | 0.2 | 0.5 | |
| -3.0 | -273 | -0.6 | 266 | 0.0 | 6.9 | -0.3 | -1.8 | 1.3 | -94 | 0.4 | 9.5 | -53 | -5.0 | 4.4 | 24 | 75 | 12 | 7.8 | -0.4 | -7.2 | -3.1 | -2.6 | -2.8 | -4.8 | -6.5 | -1.9 | -1.5 | -0.9 | -0.1 | -0.2 | -0.3 | -97 | -22 | -2.9 | 33 | 17 | -45 | 19 | 17 | 7.8 | |
| 2.0 | 2.0 | 2.0 | 1.1 | 1.9 | 5.1 | 2.0 | 1.9 | 1.9 | 5.1 | – | – | – | 5.1 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| -73 | 5.1 | 8.0 | 4.3 | -72 | -17 | 2.9 | -39 | -52 | -17 | – | – | – | -17 | – | – | 0.2 | – | – | – | – | – | -1.1 | – | -1.4 | -0.8 | 0.0 | – | 0.0 | -0.1 | 0.0 | – | -0.1 | – | 0.0 | – | 0.0 | 0.0 | – | – | – | |
| 0.0 | 265 | -17 | 232 | -24 | -6.8 | -8.8 | -3.8 | -3.8 | – | – | – | – | – | – | – | -0.2 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 0.0 | – | – | – | |
| -1.4 | 258 | -19 | -227 | -26 | 52 | 90 | 265 | -3.8 | 78 | 0.0 | 0.0 | 77 | -0.1 | 0.0 | -0.2 | 0.1 | 0.3 | 145 | 0.0 | 0.4 | 97 | -1.1 | 0.2 | 42 | 0.3 | 0.0 | 0.2 | -0.1 | 0.1 | 111 | 0.2 | -0.1 | 0.1 | -0.1 | 0.3 | -0.2 | 75 | -0.1 | 0.1 | 75 | |
| 6.3 | -5.1 | -8.0 | 40 | 16 | -2.3 | 82 | 0.4 | 0.6 | -49 | -0.5 | 3.7 | 17 | -12 | -3.9 | 12 | 67 | -0.6 | 138 | -13 | -17 | 81 | 0.3 | -17 | 22 | -25 | -26 | -26 | -22 | -24 | 88 | -24 | -119 | -46 | -28 | 6.6 | -5.6 | 9.8 | -2.7 | -3.1 | -1.6 | |
| 10 | 9.4 | 11 | 0.5 | 42 | -32 | -7.6 | 0.4 | 0.6 | -56 | -7.8 | -6.0 | -7.4 | -7.7 | -8.6 | -12 | -8.1 | -14 | -16 | -15 | -17 | -17 | 1.5 | -18 | -20 | -25 | -26 | -26 | -22 | -24 | -23 | -24 | -22 | -24 | -27 | -27 | -23 | -21 | -22 | -20 | -85 |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.